Brief: Lipigon Pharmaceuticals To Receive SEK 22.6 Mln Through Rights Issue

Lipigon Pharmaceuticals AB

22/06/2022 08:35

June 22 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * RIGHTS ISSUE HAS BEEN SUBSCRIBED FOR APPROX  SEK 17.6
MILLION,
CORRESPONDING TO A SUBSCRIPTION RATIO OF APPROXIMATELY 69.9
PERCENT
    * WILL RECEIVE APPROXIMATELY SEK 22.6 MILLION, CORRESPONDING
TO 90
PERCENT OF THE TOTAL ISSUE'S TOTAL VOLUME

Source text for Eikon:  ID:nBQN6jRHrY 
Further company coverage:  LPGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))